Latest filing published 30 Oct 2026 for BeOne Medicines Ltd., €1.3M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -97.4%Entry HK$286.00 · Close at T+365 HK$7.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Wang Xiaodong: trading record in brief
Wang Xiaodong has filed trades across 6 companies (mainly through Finansinspektionen), most often in BeOne Medicines Ltd., C-RAD AB and Clover Biopharmaceuticals, Ltd. - B. Over a trading history stretching from 23 March 2018 to 27 October 2026, the count stands at 99 filings.
Both buying and selling appear: 10 purchases worth €738k, against 46 sales worth €10.0M. No amount is published for 52 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show no purchases and 1 sale.
The latest filing, published on 30 October 2026, reports an open-market sale of €1.3M in BeOne Medicines Ltd. The last purchase on record was published on 20 June 2023, which is 1,237 days ago. Filings reach the Finansinspektionen feed a median of 3 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Wang Xiaodong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 403,364 shares@ HK$27.9241ShareXHKGHKEX:DA20261030E00102
- 403,364 sharesShareXHKGHKEX:DA20261030E00101
- 172,372 sharesShareXHKGHKEX:DA20231205E00355
- 71,890 sharesShareXHKGHKEX:DA20231205E00354
- 20,865 sharesShareXHKGHKEX:DA20230626E00376
- 413,465 sharesShareXHKGHKEX:DA20230620E00233Canonical exit: 13 Sept 2023 (T+90)
- 9,750 sharesShareXHKGHKEX:DA20230620E00258
- 340,000 sharesShareXHKGHKEX:DA20230414E00099Canonical exit: 10 Jul 2023 (T+90)
- 43,500 sharesShareXHKGHKEX:DA20230404E00421
- 67,444 sharesShareXHKGHKEX:DA20230321E00308
- 879,255 sharesShareXHKGHKEX:DA20230313E00249
- 879,255 sharesShareXHKGHKEX:DA20230313E00248
- 65,000 sharesShareXHKGHKEX:DA20230118E00354
- 65,000 sharesShareXHKGHKEX:DA20230118E00353
- 65,000 sharesShareXHKGHKEX:DA20230113E00559
- 32,500 sharesShareXHKGHKEX:DA20230112E00414
- 20,800 sharesShareXHKGHKEX:DA20230112E00413
- 11,700 sharesShareXHKGHKEX:DA20230112E00412
- 39,169 sharesShareXHKGHKEX:DA20221216E00258
- 52,000 sharesShareXHKGHKEX:DA20221130E00242
- 25,831 sharesShareXHKGHKEX:DA20221118E00203
- 65,000 sharesShareXHKGHKEX:DA20221118E00202
- 104,125 sharesShareXHKGHKEX:DA20220929E00252
- 33,410 sharesShareXHKGHKEX:DA20220909E00382
- 78,780 sharesShareXHKGHKEX:DA20220810E00322
25 of 99 declarations
